← Scroll for more →
Ligand Pharmaceuticals Inc (LGND)
Pharmaceutical Preparations
Latest Price
$312.37
TTM P/E
32.37
Normalized P/E
183.41
Div Yield
--
Book Value
48.28
P/B Ratio
6.47
Valuation metrics
adjust assumptions →EPS: $6.13
Book value / share: $51.44
Formula: √(22.5 × EPS × BVPS)
Graham Number
$84.23
73% downside
Norm. op. income: $26M (median of 7yr)
Tax rate: 21%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$47.42
85% downside
Base FCF: $70M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$300.69
4% downside
EPS: $6.13
Target P/E: 32×
Formula: EPS × P/E
P/E Fair Value
$196.16
37% downside
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3.10M | $980.0M | 15.57% | +139.1K | 2026-06-30 |
| Invesco Ltd. | 1.20M | $379.0M | 6.03% | +378.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 1.14M | $359.0M | 5.71% | +38.0K | 2026-06-30 |
| Jupiter Topco LLC | 1.04M | $328.0M | 5.22% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 871.0K | $275.0M | 4.37% | +22.9K | 2026-06-30 |
| State Street Corp | 826.5K | $261.0M | 4.15% | +47.7K | 2026-06-30 |
| FMR LLC | 762.8K | $241.0M | 3.83% | +166.7K | 2026-06-30 |
| Franklin Resources Inc | 752.0K | $237.0M | 3.78% | +178.9K | 2026-06-30 |
| Congress Asset Management Co | 659.9K | $208.0M | 3.31% | +155.3K | 2026-06-30 |
| Geode Capital Management, LLC | 589.0K | $186.0M | 2.96% | +30.1K | 2026-06-30 |